Table 1 Baseline characteristics, mean ± SD or n (%)
ARMP (n = 71) | Placebo (n = 70) | |
|---|---|---|
Age (years) | 55.6 ± 8.9 | 55.6 ± 9.3 |
Age groups | ||
< 65 years | 61 (85.9%) | 56 (80.0%) |
≥ 65 years | 10 (14.1%) | 14 (20.0%) |
Sex | ||
Males | 42 (59.2%) | 37 (52.9%) |
Females | 29 (40.8%) | 33 (47.1%) |
Smoking | ||
Yes | 17 (23.9%) | 15 (21.4%) |
No | 54 (76.1%) | 55 (78.6%) |
Weight (kg) | 80.6 ± 12.6 | 80.7 ± 12.1 |
Height (cm) | 165.5 ± 8.9 | 166.1 ± 8.0 |
BMI (kg/m2) | 29.4 ± 3.6 | 29.2 ± 3.5 |
Waist circumference (cm) | 100.8 ± 9.3 | 100.3 ± 8.7 |
SBP (mmHg) | 130.6 ± 10.5 | 131.4 ± 10.6 |
DBP (mmHg) | 80.7 ± 8.1 | 81.6 ± 8.0 |
Pulse rate (beats/min) | 65.3 ± 9.5 | 68.3 ± 10.5 |
Ongoing-lipid lowering treatment | ||
Yes | 41 (57.8%) | 41 (58.6%) |
No | 30 (42.2%) | 29 (41.4%) |
Tot-C (mg/dL) | 224.3 ± 44.7 | 218.4 ± 38.2 |
LDL-C (mg/dL) | 132.9 ± 36.5 | 128.4 ± 28.6 |
NHDL-C (mg/dL) | 173.6 ± 41.8 | 168.0 ± 36.3 |
HDL-C (mg/dL) | 50.7 ± 11.9 | 50.4 ± 12.1 |
TG (mg/dL) | 151.3 ± 82.5 | 159.6 ± 86.6 |
LDL score | 6.6 ± 7.1 | 6.8 ± 8.2 |
HbA1c (%) | 5.5 ± 0.4 | 5.5 ± 0.4 |
Glucose (mg/dL) | 103.9 ± 14.5 | 105.7 ± 17.9 |
HOMA-IR | 4.1 ± 3.2 | 4.2 ± 2.4 |
Insulin (μU/ml) | 15.7 ± 11.6 | 16.3 ± 9.0 |
CRP-Hs (Mg/L) | 1.85 ± 2.34 | 1.35 ± 1.01 |
Stratum (number of subject) | ||
Missing LDL score | 2 | 1 |
LDL score = 0 | 15 | 19 |
LDL score > 0 | 54 | 50 |